During the past several years, our core has devoted a large portion of our efforts on keeping up with the fast advancing genome engineering technologies. We have successfully used the ZFN (zinc finger nucleases), TALEN (transcription activator-like effector nucleases), and CRISPR (clustered regularly interspaced short palindromic repeat) methods to generate knockout/knockin cell lines and mouse models. In the last 12 months, we have significantly improved the efficiency and consistency for using the CRISPR method to generate knockout mouse models, as well as for using oligonucleotides-mediated homologous recombination to knockin point mutations or insert small pieces of DNA. We have successfully completed more than two dozen knockout or knockin projects using the CRISPR method. However, it still remains challenging for us to use the CRIPSR method to create conditional knockout mice in one step, and to use targeting vector-based homologous recombination to insert large pieces of DNA, such as reporter genes. We are currently attempting to solve these technical difficulties using various experimental approaches. Besides developing the new genome engineering technologies, our core is continuing to provide a variety of services using the classical mouse genetic and reproductive methodologies, including the generation of transgenic lines using the pronuclear microinjection method, the generation of knockout mice using the standard ES cell-mediated homologous recombination and blastocyst microinjection, re-deriving and resurrecting mouse lines. We have also imported the TARGATT mouse line, which enables the insertion of a single copy transgene into a predefined genomic locus. We have also been providing services on injecting stem cells into immunocompromised mice for testing their ability to form teratomas. In the past year, the cell types we injected have broadened to beyond iPSCs/ESCs, and the analysis has also extended to beyond searching for tissues from all three germ layers.

Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2015
Total Cost
Indirect Cost
Name
U.S. National Heart Lung and Blood Inst
Department
Type
DUNS #
City
State
Country
Zip Code
Jiao, Delong; Cai, Zhenyu; Choksi, Swati et al. (2018) Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis. Cell Res 28:868-870
Zhuang, Lenan; Jang, Younghoon; Park, Young-Kwon et al. (2018) Depletion of Nsd2-mediated histone H3K36 methylation impairs adipose tissue development and function. Nat Commun 9:1796
Xing, Shaojun; Shao, Peng; Li, Fengyin et al. (2018) Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. J Exp Med 215:2211-2226
Liu, Tanbin; Hu, Yi; Guo, Shiyin et al. (2018) Identification and characterization of MYH9 locus for high efficient gene knock-in and stable expression in mouse embryonic stem cells. PLoS One 13:e0192641
Vizcardo, Raul; Klemen, Nicholas D; Islam, S M Rafiqul et al. (2018) Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System. Cell Rep 22:3175-3190
Deis, Jessica A; Guo, Hong; Wu, Yingjie et al. (2018) Lipocalin 2 regulates retinoic acid-induced activation of beige adipocytes. J Mol Endocrinol :
Lin, Yongshun; Liu, Huimin; Klein, Michael et al. (2018) Efficient differentiation of cardiomyocytes and generation of calcium-sensor reporter lines from nonhuman primate iPSCs. Sci Rep 8:5907
Zhang, Yingfan; Liu, Chengyu; Adelstein, Robert S et al. (2018) Replacing nonmuscle myosin 2A with myosin 2C1 permits gastrulation but not placenta vascular development in mice. Mol Biol Cell 29:2326-2335
Lee, Hye Kyung; Willi, Michaela; Wang, Chaochen et al. (2017) Functional assessment of CTCF sites at cytokine-sensing mammary enhancers using CRISPR/Cas9 gene editing in mice. Nucleic Acids Res 45:4606-4618
Xu, Zhe; Xing, Shaojun; Shan, Qiang et al. (2017) Cutting Edge: ?-Catenin-Interacting Tcf1 Isoforms Are Essential for Thymocyte Survival but Dispensable for Thymic Maturation Transitions. J Immunol 198:3404-3409

Showing the most recent 10 out of 65 publications